Molecular Therapy
Elsevier BV, United States
- Citation score (PCS)
- 20.23
- Supplementary · 2022–2025 · 1,587 items · PCS-1.0
- Adequate sample
- How it is calculated
- Articles
- 22,910
- Crossref
- Subject
- Biological Sciences
- P1.06 · confidence high
Evaluation status
1 · Core Collection
Listed in the journal directory. Certification is by application.
3 · Citation ranking
CITATION-RANK-1.0In Biological Sciences · percentile 95.3
PNCI 2.01 · 1587 eligible items · coverage 100.0%
Snapshot: September 2026
PQF is an eligibility and quality-framework assessment. It is not a citation ranking metric and does not determine Citation Quartiles or POSI Zones. PCS is a supplementary citation indicator and does not determine the official POSI Citation Rank, Citation Percentile, Citation Quartile, or POSI Zone.
Ranking history
- 2026currentC-Q1Zone 1
Biological Sciences · rank 96 of 2,027
Editions are kept as published; each ranks the journal within its category that year.
Record details
Identity
- POSI ID · posi-data registry/ · identifier
- POSI-J-023625
- eISSN · ISSN Portal / Crossref · identifier
- 1525-0016
- OpenAlex source · OpenAlex · identifier
- S51596929
- Title · ISSN Portal / Crossref · registry
- Molecular Therapy
- Publisher · Crossref / OpenAlex · registry
- Elsevier BV
Not recorded: pISSN, ISSN country
Declared by the publisher
Stated by the journal about itself. POSI records these as declared and does not present them as measured.
- Declared country · Publisher · declared
- United States
- Language · Publisher / DOAJ · declared
- English
- Website · Publisher · declared
- www.sciencedirect.com/science/journal/15250016
Not recorded: Frequency, License, Peer review, Article processing charge
Registry and computed values
- Open access · DOAJ / OpenAlex · registry
- No
Not recorded: DOAJ status